|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.34 USD | +1.44% |
|
-0.82% | +0.38% |
| 26/06 | Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets | MT |
| 24/06 | Merck Wins European Commission Approval for KEYTRUDA Plus Padcev in Bladder Cancer | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Charts Astellas Pharma Inc.
Select your edition
All financial news and data tailored to specific country editions
